Karin bayani ― Hausa

Urticaria yawanci yana gabatarwa tare da matsanancin ƙaiƙayi masu tayar da hankali. Wani lokaci yana tare da kumburin kyallen jikin da ke ciki. Jiyya da farko ya ƙunshi guje wa abubuwan da ke jawo hankali, idan an sani. Magungunan layi na farko sun haɗa da sababbin maganin antihistamines, waɗanda za'a iya daidaita su zuwa manyan allurai idan an buƙata. Sauran magunguna kamar tsofaffi antihistamines, H2 blockers, leukotriene antagonists receptor antagonists, da karfi antihistamines, da gajeren darussa na corticosteroids za a iya ƙara a matsayin ƙarin goyon baya. A lokuta da urticaria ya ci gaba duk da waɗannan matakan, ana iya tura marasa lafiya zuwa kwararru don ƙarin hanyoyin kwantar da hankali kamar omalizumab ko cyclosporine.
Urticaria commonly presents with intensely itchy raised welts. It is sometimes accompanied by swelling of the underlying tissues. Treatment primarily involves avoiding triggers, if known. First-line medication includes newer antihistamines, which can be adjusted to higher doses if needed. Other medications like older antihistamines, H2 blockers, leukotriene receptor antagonists, stronger antihistamines, and short courses of corticosteroids can be added as extra support. In cases where urticaria persists despite these measures, patients might be referred to specialists for additional therapies such as omalizumab or cyclosporine.

Wannan bita yana zayyana sabbin ƙa'idodi don magance urticaria kuma yana ba da sabbin fahimtar musabbabin sa.
This review outlines the latest guidelines for treating urticaria and offers new understandings of its causes.

Second-generation H1-antihistamines (e.g., cetirizine, loratadine, fexofenadine), Omalizumab, Ciclosporin, and short courses only of systemic corticosteroids